…
nDatalyze Corp. generates technology-based health-related solutions. It is developing a machine-learning based online consumer mental health application. The company also engages in the manufacture and sale of essential oil CO2 extraction and alcohol-based equipment. It serves cannabis oil market. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on nDatalyze Corp (OTCQB: NDATF) is limited; available materials indicate it operates in data analytics and related technology services. Long-term growth could be supported by secular demand for analytics and AI adoption, offering small-cap exposure to digital transformation if the company executes and improves reporting.
Material risks include sparse disclosure, OTC listing and low liquidity, limited operating scale and track record, potential financing needs and execution and governance risk.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
| Income before tax | -1.23M | -1.17M | -0.70M | -0.04M | -0.26M |
| Net income | -1.23M | -1.17M | -0.70M | -0.04M | -0.26M |
| Selling general administrative | 0.65M | 0.55M | 1.04M | 0.35M | 0.34M |
| Gross profit | 0.04M | 0.23M | 0.38M | 0.32M | 0.11M |
| Reconciled depreciation | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Ebit | -0.94M | -0.93M | -0.59M | -0.05M | -0.24M |
| Ebitda | -1.23M | -1.17M | -0.69M | -0.03M | -0.25M |
| Operating income | -1.25M | -1.18M | -0.69M | -0.05M | -0.24M |
| Other operating expenses | - | 0.02M | 0.02M | 0.02M | 0.02M |
| Interest expense | 0.00M | 0.00M | 0.01M | 0.01M | 0.00M |
| Interest income | 0.02M | 0.01M | 0.00M | 0.00M | 0.00M |
| Net interest income | 0.02M | 0.00M | -0.01M | -0.01M | -0.00M |
| Total revenue | 0.17M | 0.42M | 0.66M | 0.53M | 0.16M |
| Total operating expenses | 1.42M | 1.60M | 1.35M | 0.58M | 0.40M |
| Cost of revenue | 0.13M | 0.19M | 0.29M | 0.21M | 0.05M |
| Total other income expense net | 0.00M | 0.00M | -0.00M | 0.02M | -0.02M |
| Net income from continuing ops | -1.23M | -1.17M | -0.70M | -0.04M | -0.26M |
| Net income applicable to common shares | -1.23M | -1.17M | -0.70M | -0.04M | -0.24M |
| Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
| Total assets | 0.86M | 1.71M | 0.87M | 0.67M | 0.27M |
| Intangible assets | 0.02M | 0.02M | 0.01M | 0.00M | 0.00M |
| Total liab | 0.29M | 0.08M | 0.07M | 0.04M | 0.03M |
| Total stockholder equity | 0.57M | 1.63M | 0.80M | 0.64M | 0.24M |
| Common stock | 2.45M | 2.27M | 1.02M | 0.70M | 0.37M |
| Capital stock | 2.45M | 2.27M | 1.02M | 0.70M | 0.37M |
| Retained earnings | -3.40M | -2.17M | -0.99M | -0.29M | -0.26M |
| Cash | 0.74M | 1.60M | 0.78M | 0.59M | 0.14M |
| Total current liabilities | 0.29M | 0.08M | 0.07M | 0.04M | 0.03M |
| Other stockholder equity | 0.03M | 0.71M | - | 0.04M | - |
| Property plant equipment | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total current assets | 0.84M | 1.69M | 0.87M | 0.67M | 0.26M |
| Net tangible assets | 0.55M | 1.61M | 0.79M | 0.63M | 0.24M |
| Net receivables | 0.07M | 0.02M | 0.00M | 0.01M | 0.03M |
| Inventory | 0.02M | 0.07M | 0.07M | 0.06M | 0.09M |
| Accounts payable | 0.29M | 0.08M | 0.07M | 0.04M | 0.03M |
| Non current assets total | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M |
| Breakdown | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-02-28 | 2022-02-28 | 2021-02-28 | 2020-02-29 | 2019-02-28 |
| Investments | -0.00M | -0.01M | -0.00M | -0.00M | -0.01M |
| Change to liabilities | 0.00M | 0.01M | 0.03M | 0.03M | 0.03M |
| Total cashflows from investing activities | -0.00M | -0.01M | -0.00M | -0.00M | -0.01M |
| Total cash from financing activities | 0.18M | 1.95M | 0.17M | 0.36M | 0.34M |
| Change to operating activities | 0.21M | 0.00M | -0.01M | -0.01M | -0.01M |
| Net income | -1.23M | -1.17M | -0.70M | -0.04M | -0.24M |
| Change in cash | -0.85M | 0.81M | 0.19M | 0.45M | 0.13M |
| Begin period cash flow | 1.60M | 0.78M | 0.59M | 0.14M | 0.00M |
| End period cash flow | 0.74M | 1.60M | 0.78M | 0.59M | 0.14M |
| Total cash from operating activities | -1.02M | -1.13M | 0.02M | 0.09M | -0.20M |
| Issuance of capital stock | 0.12M | 1.95M | - | 0.00M | 0.37M |
| Depreciation | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | 0.04M | 0.00M | -0.01M | 0.03M | -0.08M |
| Change to account receivables | -0.05M | -0.02M | 0.01M | 0.02M | -0.03M |
| Other cashflows from financing activities | - | 0.52M | 0.52M | 0.36M | 0.36M |
| Change to netincome | - | 0.05M | 0.69M | 0.05M | 0.12M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.21M | -0.00M | 0.02M | 0.07M | -0.09M |
| Stock based compensation | 0.00M | 0.05M | 0.69M | 0.05M | 0.13M |
| Free cash flow | -1.03M | -1.14M | 0.02M | 0.09M | -0.22M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NDATF nDatalyze Corp |
- -% |
0.08 | - | - | 35.81 | 6.40 | 30.45 | -6.98 |
| VEEV Veeva Systems Inc Class A |
-4.88 1.60% |
299.89 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
0.68 0.48% |
142.50 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-4.81 6.06% |
74.62 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.07 1.22% |
5.66 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
nDatalyze Corp. generates technology-based health-related solutions. It is developing a machine-learning based online consumer mental health application. The company also engages in the manufacture and sale of essential oil CO2 extraction and alcohol-based equipment. It serves cannabis oil market. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze Corp. in October 2021. nDatalyze Corp. was incorporated in 2018 and is headquartered in Calgary, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. James Morris Durward | Pres, CEO, Corp. Sec. & Director | 1955 |
| Mr. Dwayne A. Vinck C.A., CPA | Chief Financial Officer | 1965 |
| Mr. James Morris Durward | Chief Technical Officer, CEO, Corporate Secretary & Director | 1955 |
| Mr. Dwayne A. Vinck C.A., CPA | Chief Financial Officer | 1966 |
| Dr. Keith Courtney | President & Chief Psychiatric Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.